Synaptogenix, Inc (SNPX): O‘sishni hisobga olgan narx-foyda koeffitsiyenti
Synaptogenix, Inc. (SNPX) Altsgeymer kasalligi terapiyasini ishlab chiqmoqda va sog'liqni saqlash gigantlaridan olinadigan royalti to'lovlari orqali foydani oshirishni rejalashtirmoqda. PEG koeffitsiyenti tarixi aktivning baholash dinamikasini namoyish etadi, bunda 0.00 ushbu ko'rsatkichning joriy holatini tavsiflaydi. Patent himoyasi va noyob neyrobiologiya biznesning himoya vositasi bo'lib xizmat qiladi. AI robotlari protein kinaza aktivatori klinik sinovlarining ma'lumotlar to'plamlarini tunu kun tahlil qilib, jarayonlarni tezlashtirmoqda.
Synaptogenix, Inc. (SNPX) kompaniyasi koʻrsatkichlari kesimi va tahlili
- joriy kotirovkalar va o'rtacha qiymat prognozi:
- birja kapitallashuvi ma'lumotlari:
- biznesning balans baholash tafsilotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Jamlagan qarzning kapitalga nisbati Synaptogenix, Inc.|SNPX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati synaptogen.com|SNPX - Kompaniyaning jamlangan qarzlari|Qarzning sof aktivlarga nisbati Neurotrope|SNPX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Synaptogenix|Shoshilinch likvidlik koeffitsiyenti synaptogen.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
SNPX - Sof foyda|Kompaniya foydasi prognozi Synaptogenix, Inc.|SNPX - Narx-foyda koeffitsiyenti|Narxning kelajakdagi foydaga nisbati Synaptogenix, Inc|SNPX - Narx-foyda va o‘sish multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Neurotrope|SNPX - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Synaptogenix|SNPX - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun foydaning yillik o'sishi synaptogen.com|SNPX - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Synaptogenix, Inc.
Kompaniyaning umumiy tahlili:Synaptogenix, Inc.
P/E va o'sish sur'atlarining ushbu taqqoslovi Synaptogenix, Inc. (SNPX) kompaniyasining bozor qiymatini kutilayotgan foyda dinamikasi prizmasi orqali aks ettiradi. PEG koeffitsiyenti P/E koeffitsiyentini yillik EPS o'sish sur'atiga bo'lish orqali tuzatadi, bu esa aktivning kengayishiga nisbatan qadrsizlanganligini aniqlashga yordam beradi. FDA qarorlari va tashqi moliyalashtirishga bog'liq bo'lgan biotexnologiya kompaniyasi uchun birdan past qiymatlar muvaffaqiyatli sinovlar yakunida potentsial kapital o'sishi signalini beradi.
Raqobatdosh kompaniyalar
BIIB - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Neurocrine Biosciences Inc NBIX|RGC: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Axsome Therapeutics - PEG multiplikatori|ACAD - PEG multiplikatori|Xenon (XENE) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati VKTX (Viking Therapeutics Inc)|Narx-foyda va o‘sish multiplikatori SUPN|CPRX (Catalyst Corp) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Denali Therapeutics (DNLI)|HRMY - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori BHVN (Biohaven)|Narxning sof foyda o‘sishiga nisbati Amylyx Pharmaceuticals Inc|Trevi Pharma - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Praxis Corp|Anavex Life Sciences (AVXL) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti CBLL|PRTA (Prothena Corporation plc) - PEG multiplikatori|Alector Therapeutics (ALEC) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori ANNX (Annexon Inc.)|omeros.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Neurogene Inc. - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACIU|Voyager Therapeutics, Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Neumora NMRA|Scilex Holding Co. (SCLX) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti TVGN|ACOG (Alpha Cognition Inc) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori cogrx.com (CGTX)|Narx-foyda va o‘sish multiplikatori IKT (Inhibikase Therapeutics, Inc.)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Cassava Sciences Inc|Narxning foydaga va o‘sish sur’atiga nisbati Assertio ASRT|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Coya Therapeutics Inc (COYA)|VTGN - Narxning foydaga va o‘sish sur’atiga nisbati|OVID (Ovid Therapeutics Inc.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Acumen Pharmaceuticals, Inc. (ABOS) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati CRVO (CervoMed, Inc.)|Narx-foyda va o‘sish multiplikatori ATHE|O‘sishni hisobga olgan narx-foyda koeffitsiyenti CLNN (Clene Nanomedicine)|Narxning foydaga va o‘sish sur’atiga nisbati PepGen Inc. (PEPG)|jupiterneurosciences.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori RLMD (Relmada Therapeutics, Inc.)|Annovis Bio Inc (ANVS) - O‘sish sur’atiga tuzatilgan narx-foyda|GRCE: Narx-foyda va o‘sish multiplikatori|AIFF - PEG multiplikatori|anewmeds.com (KLTO) - Narxning foydaga va o‘sish sur’atiga nisbati|NeuroSense Therapeutics Ltd. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Reviva Pharmaceuticals Holdings, Inc.|O‘sish sur’atiga tuzatilgan narx-foyda MetaVia, Inc. MTVA|Narxning foydaga va o‘sish sur’atiga nisbati NeurAxis, Inc (NRXS)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati heliusmedical.com|Passage Bio - Narx-foyda va o‘sish multiplikatori|Neuphoria Therapeutics, Inc. (NEUP) - O‘sish sur’atiga tuzatilgan narx-foyda|NERV - Narxning foydaga va o‘sish sur’atiga nisbati|ATHA (Athira Pharma Inc) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ADXN: PEG multiplikatori|Alzamend Neuro (ALZN) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Cyclerion Therapeutics Inc.|Protagenic - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori KTTA (Pasithea Therapeutics)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati CRGT|Narxning foydaga va o‘sish sur’atiga nisbati Avenue Therapeutics, Inc ATXI|BrainStorm Cell Therapeutics Inc. (BCLI) - O‘sish sur’atiga tuzatilgan narx-foyda|Cara Therapeutics, Inc. - PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati chromocell.com (CHRO)|ELYM: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Intra-Cellular Therapies, Inc. (ITCI)|Narxning foydaga va o‘sish sur’atiga nisbati Longboard Pharma|O‘sishni hisobga olgan narx-foyda koeffitsiyenti MRNS (Marinus Pharma)|PEG multiplikatori NKGN|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati neurobopharma.com|Sage Therapeutics - Narx-foyda va o‘sish multiplikatori|TRVN: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|VIGL: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti WENA (Anew Medical Inc.)|CERE: PEG multiplikatori
